Trends in Enzyme Inhibition and Activation in Drug Design - Part II

Athina       Geronikaki

[1] 
Dmitriev, A.V.; Lagunin, A.A.; Karasev, D.A.; Rudik, A.V.; Pogodin, P.V.; Filimonov, D.A.; Poroikov, V.V. Prediction of drug-drug interactions related to inhibition or induction of drug-metabolizing enzymes. Curr. Top. Med. Chem.,  2019, 19(5), 319-336.
[PMID: 30674264] 
[2] 
Saxena, A.K.; Singh, A. Mycobacterial tuberculosis enzyme targets and their inhibitors. Curr. Top. Med. Chem,  2019, 19(5), 337-355.
[3] 
Tratrat, C.; Haroun, M.; Xenikakis, I.; Liaras, K.; Tsolaki, E.; Eleftheriou, P.; Petrou, A.; Aldhubiab, B.; Attimarad, M.; Venugopala, K.N.; Harsha, S.;
Elsewedy, H.S.; Geronikaki, A. Soković, M. Design, synthesis, evaluation of antimicrobial activity and docking studies of new thiazole-based chalcones. Curr. Top. Med. Chem,  2019, 19(5), 356-375.
[4] 
Jangra, S.; Purushothaman, G.; Juvale, K.; Ravi, S.; Menon, A.; Kirubakaran, S.; Thiruvenkatam, V. Synthesis and in vitro enzymatic studies of new
3-aryldiazenyl indoles as promising Helicobacter pylori IMPDH inhibitors. Curr. Top. Med. Chem.,  2019, 19(5), 376-382.
[PMID: 30827248] 
[5] 
Eleftheriou, P.; Therianou, E.; Lazari, D.; Dirnali, S.; Micha, A. Docking assisted prediction and biological evaluation of sideritis l. components with
PTP1B inhibitory action and probable anti-diabetic properties. Curr. Top. Med. Chem,  2019, 19(5), 383-392.
[PMID: 30806317] 

Rights & Permissions Print Export Cite as

Article Metrics

27

4

1

Journal Information

For Authors & Reviewers

Explore Articles

Open Access

For Visitors

DOI https://dx.doi.org/10.2174/156802661905190418152713	Print ISSN 1568-0266
Publisher Name Bentham Science Publisher	Online ISSN 1873-4294

Current Topics in Medicinal Chemistry

Trends in Enzyme Inhibition and Activation in Drug Design - Part II

Related Journals

Related Books

Related Articles